Abbott: Gastrointestinal Diseases trials

The registry lists 10 Gastrointestinal Diseases studies with Abbott as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 2 3Phase 3 2No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and CancerCompletedNCT01397747Results posted
• Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)CompletedNCT02503696
• Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract CancersTerminatedNCT02503631
• Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel DiseaseCompletedNCT01819766
• Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation TestingCompletedNCT01600209
• Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development StudiesCompletedNCT01260168
• Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediatric PopulationCompletedNCT01191112Phase 3
• Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative ColitisCompletedNCT00073047Phase 2
• A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's DiseaseCompletedNCT00072943Phase 2
• Research Study in Patients With Severe Ulcerative ColitisCompletedNCT00032305Phase 2/3